Stock 950 LEE'S PHARMACEUTICAL HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Lee's Pharmaceutical Holdings Limited

Equities

950

KYG5438W1116

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:35 2024-04-19 am EDT 		5-day change 1st Jan Change
1.16 HKD 0.00% Intraday chart for Lee's Pharmaceutical Holdings Limited -1.69% -24.18%
Apr. 19 Lee’s Pharmaceutical's 2023 Profit Slumps 67% MT
Mar. 26 Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Lee's Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the development, manufacturing, marketing and sales of pharmaceutical products. The Company operates its business through two segments. The Imported Products segment is engaged in the sale of imported products. Its imported products include Keyan injection, Fipril oral solution and others. The Proprietary Products segment is engaged in the manufacture and sale of self-developed products. Its R&D products include Resilicon Tablets, ADASUVE Inhalation Powder and others. The Company's medicines cover the fields of cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology. The Company mainly operates its business in mainland China, Hong Kong and Taiwan.

Number of employees: 1,060

Sales per Business

HKD in Million2021Weight2022Weight Delta
Licensed-in Products
59.5 %
749 59.2 % 733 59.5 % -2.11%
Proprietary Products
40.5 %
517 40.8 % 500 40.5 % -3.33%

Sales per region

HKD in Million2021Weight2022Weight Delta
China
100.0 %
1,266 100.0 % 1,233 100.0 % -2.61%

Managers

Managers TitleAgeSince
Wanee Leelalertsuphakun CEO
 Chief Executive Officer 71 97-03-31
Xiao Yi Li FOU
 Founder 62 93-12-31
Siu Fong Lee CHM
 Chairman 67 97-03-31
Yiu Ming Chow DFI
 Director of Finance/CFO 50 14-10-06
Lei Yin CTO
 Chief Tech/Sci/R&D Officer 51 13-12-31
Sabino Iliceto CTO
 Chief Tech/Sci/R&D Officer - 22-01-31
Yuanjue Sun CTO
 Chief Tech/Sci/R&D Officer - 21-08-31
Yueshen Chen ADM
 Chief Administrative Officer 65 -
Victor Kailok Tsui PRN
 Corporate Officer/Principal - 11-12-31
Surasak Lelalertsuphakun PRN
 Corporate Officer/Principal 40 15-03-31

Members of the board

Members of the board TitleAgeSince
James Gale BRD
 Director/Board Member 74 22-01-01
Yau Ching Chan BRD
 Director/Board Member 61 02-01-13
Xiao Yi Li FOU
 Founder 62 93-12-31
Siu Fong Lee CHM
 Chairman 67 97-03-31
Wanee Leelalertsuphakun CEO
 Chief Executive Officer 71 97-03-31
Wah Keung Tsim BRD
 Director/Board Member 65 04-09-19
Yee Wah Cheang BRD
 Director/Board Member 49 23-05-16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 588,835,343 187,726,180 ( 31.88 %) 0 31.88 %

Shareholders

NameEquities%Valuation
Huby Technology Ltd.
19.36 %
114,000,625 19.36 % 17 M $
Paolo Cavazza
13.01 %
76,580,898 13.01 % 12 M $
GL Capital Group
12.93 %
76,165,488 12.93 % 12 M $
Xiao Yi Li
7.271 %
42,815,266 7.271 % 7 M $
Gortune Investment Co., Ltd.
5.278 %
31,076,999 5.278 % 5 M $
Panacea Venture
5.010 %
29,500,000 5.010 % 4 M $
Fidelity Management & Research Co. LLC
4.959 %
29,201,000 4.959 % 4 M $
UBS Switzerland AG (Investment Management)
4.951 %
29,154,998 4.951 % 4 M $
Shuk Ping Vicky Lue
2.717 %
16,000,000 2.717 % 2 M $
Wanee Leelalertsuphakun
1.173 %
6,909,500 1.173 % 1 M $

Holdings

NameEquities%Valuation
SOLASIA PHARMA K.K.
0.93%
 1,662,522 0.93% 362,496 $

Company contact information

Lee's Pharmaceutical Holdings Ltd.

1/F, Building 20 East Phase 3

, Hong Kong

+852 2314 1282

http://www.leespharm.com
address Lee's Pharmaceutical Holdings Limited(950)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
1.16 HKD
Average target price
1 HKD
Spread / Average Target
-13.79%
Consensus

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
LEE'S PHARMACEUTICAL HOLDINGS LIMITED Stock Lee's Pharmaceutical Holdings Limited
-24.18% 87.22M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+24.60% 672B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.08% 550B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.63% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.37% 317B
ABBVIE INC. Stock AbbVie Inc.
+7.38% 292B
ASTRAZENECA PLC Stock AstraZeneca PLC
+3.26% 211B
NOVARTIS AG Stock Novartis AG
+0.78% 203B
PFIZER, INC. Stock Pfizer, Inc.
-9.69% 144B
AMGEN INC. Stock Amgen Inc.
-6.63% 141B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 950 Stock
  4. Company Lee's Pharmaceutical Holdings Limited